Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Generate Biomedicines, Inc. (GENB) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Generate Biomedicines, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2100782.
Total stock buying since 2026: $150,060,800.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 9,378,800 | $150,060,800 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-03 | 9,378,800 | $150,060,800 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-02 | Grous Beth (Chief People Officer) | Buy | 300 | 16.00 | 4,800 |
| 2026-03-02 | Silvers Jason (President & CFO) | Buy | 2,000 | 16.00 | 32,000 |
| 2026-03-02 | Fpn Ii, L.p. | Buy | 4,687,500 | 16.00 | 75,000,000 |
| 2026-03-02 | Fpn General Partner Llc | Buy | 4,687,500 | 16.00 | 75,000,000 |
| 2026-03-02 | Mendillo Jane L | Buy | 1,500 | 16.00 | 24,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of GENB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Generate Biomedicines, Inc. (symbol GENB, CIK number 2100782) see the Securities and Exchange Commission (SEC) website.